DarioHealth (DRIO) Reports Q4 Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- Lula, Brazil's iconic working class president, wins historic fourth term in dramatic comeback
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
- Accenture shares fall on insider sales and analyst downgrade
- Wall Street closes lower to end rocky week
- Credo Technology shares fall on competition concerns
DarioHealth Reports Fourth Quarter and Year End 2019 Results
March 17, 2020 6:30 AM EDTNEW YORK, March 17, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, today reported financial results for the fourth quarter and full year ended December 31, 2019 and provided a corporate and commercial update.
Transformed the business into a software as a service (SAAS)-based membership model with recurring revenues and potential for high margin profile Opened multiple channels within the business-to-business-to-consumer (B2B2C) marketplace laying the foundation for potential future growth with expected lower customer acquisition costs Produced additional... More


